Edwin Tucker
Hoofd Techniek/Wetenschap/O&O bij JASPER THERAPEUTICS, INC.
Vermogen: - $ op 30-04-2024
Actieve functies van Edwin Tucker
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| JASPER THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 12-06-2023 | - |
| The Royal College of Physicians | Corporate Officer/Principal | - | - |
Loopbaan van Edwin Tucker
Eerdere bekende functies van Edwin Tucker
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| MIRUM PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 28-10-2019 | 01-11-2021 |
| Acerta Pharma LLC | Compliance Officer | 01-01-2015 | 01-01-2018 |
| Operationeel Directeur | 01-01-2015 | 01-01-2019 | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01-01-2013 | 01-01-2015 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01-01-2010 | 01-01-2013 |
Goldfinch Bio, Inc.
 Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA. | Hoofd Techniek/Wetenschap/O&O | - | - |
Opleiding van Edwin Tucker
| University of Leeds | Doctorate Degree |
| University of Connecticut | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 8 |
| Verenigd Koninkrijk | 3 |
Operationeel
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 4 |
| Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| MIRUM PHARMACEUTICALS, INC. | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| JASPER THERAPEUTICS, INC. | Finance |
| Bedrijven in privébezit | 3 |
|---|---|
| Acerta Pharma LLC | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Goldfinch Bio, Inc.
Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Goldfinch Bio, Inc. operates as a biotechnology company. It focuses on discovering and developing precision therapies for patients with kidney disease. The firm develops and manufactures medicines. The company was founded by Joseph Vincent Bonventre, Anna Greka, Fridhelm Hildebrandt, Daniel MacArthur, Stefan Somlo and Peter Mundel in December 2016 and is headquartered in Cambridge, MA. | Health Technology |
- Beurs
- Insiders
- Edwin Tucker
- Ervaring